ELICHEN, that's my feeling as well.
There will be a spark, whether it's release of Phase 1 data, dramatically positive peer review and media attention, jv, dramatically rising volume and share price, uplist, etc.,etc.; and the key thing that happens then is the mutual fund and hedge funds 'HERD MENTALITY' accumulation of the the new 'darling' investment place to be, just like what's happened the past year with the burgeoning marijuana market stocks and start up companies.
Which by the way, imo, are not even in the first inning yet in terms of their inevitable growth, given the right choices to invest in imo.
The same analogy holds for stem cell stocks in curing/stabilizing eye diseases. When the spark hits, whatever it might be as noted, just like the marijuana stocks, the money money will go to the biggest and best out there and , at this time, there's really ONE company that fits the bill, and that's ACTC.
It's clearly a media, volume and share price explosion waiting to happen. In what form we don't know yet, but it will happen and it looks like soon with the current dynamics surrounding the company.
News 
Market Data 
Discover 
AI
